KaliVir Declares US FDA Nods IND Application To Perform Phase Study

KaliVir Immunotherapeutics, Inc., a biotechnology company developing cutting-edge, multi-mechanism oncolytic virus immunotherapy programs

DCGI Calls Upon Indian Pharma for Raise Standards to Global Level

India, being the prominent manufacturing hub for pharmaceuticals catering to the medicinal needs of the global population

NPPA Approves Manufacturer Change for Brands Under Guidelines

The approval to shift manufacturing to their own facilities at the existing retail price has been granted

US FDA Approves Innovative Therapy for Blood Cancer

The FDA has given its approval for Tibsovo (ivosidenib) to be used in the treatment of adult patients

US FDA Approves Celltrion's Zymfentra for Bowel Disease

Celltrion USA announced that the US Food and Drug Administration (FDA) has approved

IISER Bhopal Scientist Develop Biomedical Adhesive to fix Tissues

Researchers at the Indian Institute of Science Education and Research Bhopal, also known as IISER

US FDA Approves AstraZeneca's sBLA for Self-administration

The US Food and Drug Administration (FDA) has accepted AstraZeneca's Supplemental Biologics

DoP Implementing Operational Guidelines Under PLI Scheme

The Department of Pharmaceuticals (DoP) has made changes to the operational guidelines for the pharmaceutical production

AstraZeneca's Self-administered Flu Vaccine to be Approved by FDA

FluMist, AstraZeneca's nasal spray flu vaccination that has been on the market for two decades, might be ready for self-administration as soon as next year.

Torrent Pharma Net profit Rises 24% To Rs 386 Crore

Torrent Pharmaceuticals Ltd recorded a consolidated net profit of 386 crore for the September quarter, up 24% from the previous year, while revenue increased 16% from 2,291 crore to 2,660 crore. Its earnings before interest, taxes, depreciation...

© 2025 India Pharma Outlook. All Rights Reserved.